Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)

被引:0
|
作者
Cindy T. McEvoy
Philip L. Ballard
Robert M. Ward
Joseph E. Rower
Rajan Wadhawan
Mark L. Hudak
Joern-Hendrik Weitkamp
Julia Harris
Jeanette Asselin
Cheryl Chapin
Roberta A. Ballard
机构
[1] Oregon Health & Science University,Department of Pediatrics
[2] University of California San Francisco,Department of Pediatrics
[3] University of Utah,Department of Pediatrics
[4] University of Utah,Department of Pharmacology and Toxicology
[5] AdventHealth for Children,Department of Pediatrics
[6] University of Florida College of Medicine-Jacksonville,Department of Pediatrics
[7] Vanderbilt University Medical Center,Department of Pediatrics
[8] Oakland Children’s Hospital,Department of Pediatrics
来源
Pediatric Research | 2020年 / 88卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:629 / 636
页数:7
相关论文
共 45 条
  • [21] High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns
    Siddappa, Ashajyothi M.
    Olson, Rose M.
    Spector, Miriam
    Northrop, Elise
    Zamora, Tara
    Brearley, Ann M.
    Georgieff, Michael K.
    Rao, Raghavendra
    JOURNAL OF PEDIATRICS, 2020, 222 : 98 - +
  • [22] A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia
    M H Kirschbaum
    T Synold
    A S Stein
    J Tuscano
    J M Zain
    L Popplewell
    C Karanes
    M R O'Donnell
    B Pulone
    A Rincon
    J Wright
    P Frankel
    S J Forman
    E M Newman
    Leukemia, 2011, 25 : 1543 - 1547
  • [23] A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia
    Kirschbaum, M. H.
    Synold, T.
    Stein, A. S.
    Tuscano, J.
    Zain, J. M.
    Popplewell, L.
    Karanes, C.
    O'Donnell, M. R.
    Pulone, B.
    Rincon, A.
    Wright, J.
    Frankel, P.
    Forman, S. J.
    Newman, E. M.
    LEUKEMIA, 2011, 25 (10) : 1543 - 1547
  • [24] Rectal Indomethacin Dose Escalation for Prevention of Post-ERCP Pancreatitis in High-Risk Patients: Preliminary Report of a Multicenter Randomized Trial (RIDE Trial)
    Fogel, Evan L.
    Lehman, Glen A.
    Tarnasky, Paul
    Cote, Gregory A.
    Kwon, Richard
    Watkins, James L.
    Schmidt, Suzette E.
    Sherman, Stuart
    Elta, Grace H.
    Easler, Jeffrey J.
    Pleskow, Douglas K.
    El Hajj, Ihab I.
    Waljee, Akbar K.
    Guda, Nalini M.
    Gromski, Mark A.
    Arol, Seena
    Korsnes, Sheryl
    McHenry, Lee, Jr.
    Suarez, Alejandro L.
    Spitzer, Rebecca
    MIller, Marilyn
    Hofbauer, Maria
    Elmunzer, B. Joseph
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1 - S1
  • [25] Effects of High-Frequency Oscillatory Ventilation With Volume Guarantee During Surfactant Treatment in Extremely Low Gestational Age Newborns With Respiratory Distress Syndrome: An Observational Study
    Tana, Milena
    Paladini, Angela
    Tirone, Chiara
    Aurilia, Claudia
    Lio, Alessandra
    Bottoni, Anthea
    Costa, Simonetta
    Tiberi, Eloisa
    Pastorino, Roberta
    Vento, Giovanni
    FRONTIERS IN PEDIATRICS, 2022, 9
  • [26] Impact of Postnatal Corticosteroid Use on Neurodevelopment at 18 to 22 Months' Adjusted Age: Effects of Dose, Timing, and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants
    Wilson-Costello, Deanne
    Walsh, Michele C.
    Langer, John C.
    Guillet, Ronnie
    Laptook, Abbot R.
    Stoll, Barbara J.
    Shankaran, Seetha
    Finer, Neil N.
    Van Meurs, Krisa P.
    Engle, William A.
    Das, Abhik
    PEDIATRICS, 2009, 123 (03) : e430 - e437
  • [27] Panobinostat as maintenance therapy after allogeneic stem cell transplantation in patients with high-risk MDS or AML: Results from the dose-escalation part of the PANOBEST trial
    Bug, G.
    Burchert, A.
    Wagner, E. M.
    Kroeger, N.
    Jedlickova, Z.
    Gueller, S.
    Wolf, A.
    Huenecke, S.
    Bader, P.
    Serve, H.
    Ottmann, O. G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S59 - S59
  • [28] Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial
    Juul, Sandra E.
    Vu, Phuong T.
    Comstock, Bryan A.
    Wadhawan, Rajan
    Mayock, Dennis E.
    Courtney, Sherry E.
    Robinson, Tonya
    Ahmad, Kaashif A.
    Bendel-Stenzel, Ellen
    Baserga, Mariana
    LaGamma, Edmund F.
    Downey, L. Corbin
    O'Shea, Michael
    Rao, Raghavendra
    Fahim, Nancy
    Lampland, Andrea
    Frantz, Ivan D.
    Khan, Janine
    Weiss, Michael
    Gilmore, Maureen M.
    Ohls, Robin
    Srinivasan, Nishant
    Perez, Jorge E.
    McKay, Victor
    Heagerty, Patrick J.
    JAMA PEDIATRICS, 2020, 174 (10) : 933 - 943
  • [29] A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome
    Koo, Ray Mun
    Wong, Eric
    Davis, Joanne E.
    Perera, Travis
    Lim, Andrew
    Koldej, Rachel M.
    Ritchie, David S.
    BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 1025 - 1027
  • [30] Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial
    Fogel, Evan L.
    Lehman, Glen A.
    Tarnasky, Paul
    Cote, Gregory A.
    Schmidt, Suzette E.
    Waljee, Akbar K.
    Higgins, Peter D. R.
    Watkins, James L.
    Sherman, Stuart
    Kwon, Richard S. Y.
    Elta, Grace H.
    Easler, Jeffrey J.
    Pleskow, Douglas K.
    Scheiman, James M.
    El Hajj, Ihab I.
    Guda, Nalini M.
    Gromski, Mark A.
    McHenry, Lee, Jr.
    Arol, Seena
    Korsnes, Sheryl
    Suarez, Alejandro L.
    Spitzer, Rebecca
    Miller, Marilyn
    Hofbauer, Maria
    Elmunzer, B. Joseph
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (02): : 132 - 141